10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
The current price of TXG.BOATS is $21.48 USD — it has decreased by -0.37% in the past 24 hours. Watch 10x Genomics stock price performance more closely on the chart.
What is 10x Genomics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange 10x Genomics stocks are traded under the ticker TXG.BOATS.
What is 10x Genomics market cap?▼
Today 10x Genomics has the market capitalization of 2.53B
When is the next 10x Genomics earnings date?▼
10x Genomics is going to release the next earnings report on May 06, 2026.
What were 10x Genomics earnings last quarter?▼
TXG.BOATS earnings for the last quarter are -0.13 USD per share, whereas the estimation was -0.2 USD resulting in a +35.89% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is 10x Genomics revenue for the last year?▼
10x Genomics revenue for the last year amounts to 1.29B USD.
What is 10x Genomics net income for the last year?▼
TXG.BOATS net income for the last year is -87.09M USD.